| Model Number |
FDS50040 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Hemorrhage/Blood Loss/Bleeding (1888); Visual Impairment (2138); Thrombosis/Thrombus (4440)
|
| Date of Event |
09/15/2020
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The subject device remained implanted.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient had experienced acute central retinal artery thrombosis approximately 32 hours post deployment of the subject flow diverter.The patient experienced acute loss of vision in ipsilateral eye of implantation.The subject flow diverter was implanted in the cavernous segment of the internal carotid artery (ica) and no difficulties were encountered during the procedure.Patient received 6mg of ia tpa in carotid and external artery as a medical intervention to treat the thrombosis and loss of vision.The vision improved after the patent received the medication.16 hours post tpa patient¿s scan showed many microhemorrhages and medical management was used to following indication of hemorrhages.No other information was provided.
|
| |
|
Event or Problem Description
|
|
It was reported that the patient had experienced acute central retinal artery thrombosis approximately 32 hours post deployment of the subject flow diverter.The patient experienced acute loss of vision in ipsilateral eye of implantation.The subject flow diverter was implanted in the cavernous segment of the internal carotid artery (ica) and no difficulties were encountered during the procedure.Patient received 6mg of ia tpa in carotid and external artery as a medical intervention to treat the thrombosis and loss of vision.The vision improved after the patent received the medication.16 hours post tpa patient¿s scan showed many microhemorrhages and medical management was used to following indication of hemorrhages.No other information was provided.
|
| |
|
Additional Manufacturer Narrative
|
|
Due to the automated mes system there are controls in the manufacturing process to ensure the product met specifications upon release.Visual and functional testing could not be performed since the device was implanted in the patient.The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.Based upon medical review, the harm observed in the complaint is anticipated in nature as per the device risk assessment.As a product related root cause does not apply and the issue is due to a known physiological effect of the procedure and/or patient condition noted with the directions for use, product labeling and/or risk documentation files, an assignable cause of anticipated procedural complication will be assigned to this complaint.
|
| |
|
Search Alerts/Recalls
|